Fibrocell HK Joint Venture

Fibrocell and Hefei Meifu Bio-Tech Limited Co. (Meifu) have formed a joint venture to develop and market autologous fibroblast cell therapies in Asia, excluding Japan.

Notably, women account for more than half of China’s estimated $15 billion in luxury sales in 2010 (McKinsey & Company), and China is home to 11 of the world’s 20 richest self-made women (Hurun Report). In addition, the average female luxury consumer in China spent 22% more in 2010 than she did in 2008; by 2020, China is expected to be the world’s largest luxury market.